Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Forte Biosciences Inc (FBRX)

Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
5 Stocks Retail Investors Are Most Bullish On At Mid-Day Stocktwits - Wed Nov 20, 12:18PM CST

Retailers went overboard about a couple of biotech stocks and a MedTech name, among others on Wednesday.

FBRX : 16.00 (+2.30%)
QSI : 1.6200 (+33.88%)
DUOT : 4.58 (-6.34%)
IBB : 137.96 (+1.37%)
SLXN : 0.3070 (-4.18%)
SPY : 595.51 (+0.31%)
XBI : 96.24 (+2.06%)
ZIM : 23.78 (-1.86%)
Forte Biosciences Stock More Than Doubles On Oversubscribed $53M Private Placement: Retail Goes Wild Stocktwits - Wed Nov 20, 11:30AM CST

The funds will support clinical development of FB102, Forte’s proprietary anti-CD122 monoclonal antibody targeting autoimmune and autoimmune-related diseases.

FBRX : 16.00 (+2.30%)
VXF : 203.42 (+1.71%)
VTI : 296.51 (+0.49%)
ONEQ : 74.95 (+0.23%)
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy Business Wire - Tue May 2, 2023

The Board of Directors (the “Board”) of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product...

MMED.NE : 14.9000 (+9.48%)
MNMD : 7.56 (+6.63%)
INCY : 71.72 (+1.89%)
SGEN : 228.74 (-0.07%)
PFE : 25.65 (+2.07%)
FBRX : 16.00 (+2.30%)
JAZZ : 126.67 (+1.25%)
ALC : 85.99 (+0.49%)
MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting Business Wire - Tue Apr 18, 2023

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders,...

MMED.NE : 14.9000 (+9.48%)
MNMD : 7.56 (+6.63%)
INCY : 71.72 (+1.89%)
BMY : 58.87 (+1.10%)
SGEN : 228.74 (-0.07%)
FBRX : 16.00 (+2.30%)
Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update Business Wire - Fri Mar 31, 2023

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced full year 2022 results and provided a business update.

FBRX : 16.00 (+2.30%)
Mr. David Gryska Appointed to Forte Biosciences Board of Directors Business Wire - Thu Jan 12, 2023

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), announced today that Mr. David Gryska has been appointed to the Forte Biosciences Board of Directors.

FBRX : 16.00 (+2.30%)
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update Business Wire - Mon Nov 14, 2022

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced third quarter 2022 results and provided a business update.

FBRX : 16.00 (+2.30%)
Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors Business Wire - Mon Nov 14, 2022

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), announced today that Dr. Scott Brun, M.D. has been appointed to the Forte Biosciences Board of Directors.

FBRX : 16.00 (+2.30%)
Camac Partners Condemns Forte Biosciences’ Seemingly Defensive and Unjustifiable Capital Raise Business Wire - Wed Aug 17, 2022

Camac Partners, LLC (together with its affiliates, "Camac" or “we”), which is one of the largest shareholders of Forte Biosciences, Inc. (Nasdaq: FBRX) (“Forte” or the “Company”), today expressed...

FBRX : 16.00 (+2.30%)
Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update Business Wire - Mon Aug 15, 2022

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced second quarter 2022 results and provided a business update.

FBRX : 16.00 (+2.30%)

Barchart Exclusives

How to Invest for Kids: Understanding the Basics Barchart - Sat Nov 23, 1:30PM CST
A good way to show kids the value of compounding money is to ask if they’d rather have a $100 bill today or a penny that doubles every day for 30 days. They will be surprised to hear that in 30 days, that penny would be worth about $5.4 million dollars! Here's a guide to the types of accounts you can open for your children or grandchildren. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot